Join our growing community to challenge mainstream media bias and fix the news
US authorizes emergency use of Regeneron antibody drug

US authorizes emergency use of Regeneron antibody drug

The US Food and Drug Administration has allowed emergency usage of a second antibody drug to fight COVID-19. The drug, produced by Regeneron Pharmaceuticals Inc., was also administered to U.S. President Donald Trump when he was sickened last month. According to the FDA, the treatment is meant for mild cases of COVID-19 and not for those who have been hospitalized.

Kathy
Kathy
Top in U.S.